A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

NCT04867200 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Anticoagulant

Interventions

DRUG: Lixiana(D006)
DRUG: CKD-344

Sponsor

Chong Kun Dang Pharmaceutical